Chronic lymphocytic leukemia is a type of blood cancer that usually grows slowly and can be treated with chemotherapy. But in some cases, patients do not respond to this traditional treatment.

Chronic myeloid leukemia (CML) was once a dire diagnosis. Now the disease can be treated successfully in most people. The disease has to be treated over many years to be kept under control.

Being diagnosed with leukemia or lymphoma can be a major life change for patients. With new advances in medicine, they may have some respite. 

Though more common in adults, acute myeloid leukemia (AML) is the second most common type of blood cancer in children. If untreated, the disease can be fatal in just a few months.  

A new medication that was thought to hold promise for non-Hodgkin lymphoma has been stopped. Pfizer announced it has halted its trial of the investigational compound inotuzumab ozogamicin.

Today, people with chronic myeloid leukemia (CML) are leading pretty much normal lives. They can thank a variety of medications for being alive.

Stem cell transplants can – and do – save the lives of very sick kids. New research has discovered that the transplant is often just the start of hospital stays for these young patients.

Scientists have entered a brave new world when it comes to treating childhood leukemia. New therapies now being tested may completely change the way one type of blood cancer is treated in children.

Huge advances have been made in the understanding of multiple myeloma. There are a variety of approaches for treating this blood cancer. The trick is to provide what’s best for the individual patient.

Fear that the treatment for one condition might cause another condition, like cancer, could prevent people from taking needed medications. But should this be a concern for lupus patients?